BEIJING, Jan 12, 2021--In November 2020, The European Commission (EC) published a Recommendation on the use of rapid antigen tests for the diagnosis of SARS-CoV-2 infection. Following the instruction, earlier this January Austrian Federal Ministry of Education, Science and Research published public guidance for national-wide COVID-2019 tests in all schools.
Around five million SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immuno-chromatography) (Supplier: Beijing Lepu Medical Technology Co., Ltd. China) for students will be provided to all schools in Austria. Heinz Faßmann, Bundesminister für Bildung, Wissenschaft und Forschung, advocates that more children take part in this regular antigen testing, the safer the school life becomes for children and everyone else.
As the case number of SARS-CoV-2 infections continues to rise, tests demand increas-es as well: Member State's health systems and medical laboratories are under pres-sure and testing capacities are often exceeded. Antigen tests support prompt test results in 15 mins, particularly suitable for detecting a high viral load. This means people who are highly contagious can be quickly identified.
Responses from Beijing Lepu Medical Technology Co., Ltd. that high quality and prompt products supply will be guaranteed to defend the safety for all Austrian students. The company continues to make progress with its pipeline and continues to work with EU regulatory agencies on timelines, and more COVID-2019 related tests are coming soon in European markets to support sufficient and quick diagnosis fighting COVID-19:
• 2019-nCoV Neutralization Antibody Test Kit (Fluorescence Immunochromatography)
• 2019-nCoV Neutralization Antibody Test kit (Colloidal Gold Immunochromatography)
• 2019-nCoV Neutralization Antibody Test Kit (ELISA)
Contact your local sales representative, or visit en.lepumedical.com for more informations.